A Study of Remternetug (LY3372993) in Healthy Participants
Clinical trial NCT07056309 · COMPLETED
Trial details
- NCT number
- NCT07056309
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-24
- Primary completion
- 2025-12-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.